Fujirebio Europe Launches the INNO-LiPA® HCV 2.0 Genotyping Assay, an …
뉴스와이어신상품
0
44
0
03.19 17:20
Fujirebio Europe today announced the availability* of the INNO-LiPA HCV 2.0 Genotyping assay. The product, previously distributed by Siemens Healthcare Diagnostics Inc. under the name VERSANT HCV Genotype 2.0, is a line probe assay, for in vitro d...
